Follow
Kristen Fessele
Title
Cited by
Cited by
Year
Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials
JM O’Connor, KL Fessele, J Steiner, K Seidl-Rathkopf, KR Carson, ...
JAMA oncology 4 (8), e180798-e180798, 2018
1012018
Managing the multiple causes of nausea and vomiting in the patient with cancer.
KS Fessele
Oncology Nursing Forum 23 (9), 1409-15; quiz 1416, 1996
471996
Setting the bar: developing quality measures and education programs to define evidence-based, patient-centered, high-quality care.
K Fessele, S Yendro, G Mallory
Clinical Journal of Oncology Nursing 18, 2014
302014
Financial support models: a case for use of financial navigators in the oncology setting
D Sherman, KL Fessele
Clin J Oncol Nurs 23 (5), 14-18, 2019
262019
Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research
MSY Thong, RJ Chan, C van den Hurk, K Fessele, W Tan, D Poprawski, ...
Supportive Care in Cancer 29 (1), 7-10, 2021
202021
Primer in genetics and genomics, article 6: basics of epigenetic control
KL Fessele, F Wright
Biological Research for Nursing 20 (1), 103-110, 2018
202018
Rigor and reproducibility: a systematic review of salivary cortisol sampling and reporting parameters used in cancer survivorship research
JM Hulett, KL Fessele, MF Clayton, LH Eaton
Biological research for nursing 21 (3), 318-334, 2019
182019
Factors associated with unplanned hospitalizations among patients with nonmetastatic colorectal cancers intended for treatment in the ambulatory setting
KL Fessele, MJ Hayat, DK Mayer, RL Atkins
Nursing research 65 (1), 24-34, 2016
182016
The rise of big data in oncology
KL Fessele
Seminars in Oncology Nursing 34 (2), 168-176, 2018
162018
Financial Toxicity: Management as an adverse effect of cancer treatment.
KL Fessele
Clinical Journal of Oncology Nursing 21 (6), 2017
152017
Predictors of unplanned hospitalizations in patients with nonmetastatic lung cancer during chemotherapy
KL Fessele, MJ Hayat, RL Atkins
Oncology nursing forum 44 (5), E203, 2017
132017
Nursing Through the Ages: Benefits of a Generationally Diverse Staff Mix.
KL Fessele
ONS connect 24 (5), 2009
132009
Non-Hodgkin's lymphoma
BA Bilodeau, KL Fessele
Seminars in oncology nursing 14 (4), 273-283, 1998
131998
Medication safety in cancer clinical trials: An analysis of medication error reports at a comprehensive cancer center
MP Kane, K Fessele, J Gordilis-Perez, S Schwartz, S Lisi, J Nishioka, ...
Journal of Clinical Oncology 25 (18_suppl), 6547-6547, 2007
122007
Chemotherapy use near end of life (EOL): Measuring real world benchmarks.
J Kraut, J Gippetti, D Peterson, V Agarwala, C Revol, KL Fessele, ...
Journal of Clinical Oncology 35 (8_suppl), 228-228, 2017
82017
Primer in genetics and genomics, article 5—Further defining the concepts of genotype and phenotype and exploring genotype–phenotype associations
F Wright, K Fessele
Biological research for nursing 19 (5), 576-585, 2017
72017
A retrospective, cross-sectional study of self-reported exercise and depression among survivors of breast, gynecologic and thoracic cancer
M D’Errico, KL Fessele
Oncology nursing forum 48 (1), 59, 2021
62021
Improving practice one patient, one nurse, one day at a time: Design and evaluation of a quality education workshop for oncology nurses
MSN Leah Scaramuzzo, RN Elaine Sein, MSN Karen Harrison, ...
Clinical Journal of Oncology Nursing 17 (6), 584, 2013
62013
Work-Life Balance.
KL Fessele
Ons Connect 23 (4), 2008
62008
A model for building research capacity and infrastructure in oncology: a nursing research fellowship
AMM Ebstein, M Barton-Burke, KL Fessele
Asia-Pacific Journal of Oncology Nursing 7 (4), 312-318, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20